Eliem Therapeutics Inc. (ELYM)

AI Score

Unlock

5.11

-0.05 (-0.97%)

At close: Oct 02, 2024, 8:00 PM

5.11

0.00%

After-hours: Oct 02, 2024, 07:46 PM EDT

Eliem Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	223.14M	105.03M	93.11M	57.35M	25.29M	34.44M	43.59M	35.94M	32.6M	31.93M	46.92M	62.82M	99.48M	47.91M	20.49M	-21.22M
Short-Term Investments	n/a	n/a	13.69M	50.08M	77.34M	74.94M	79.98M	86.67M	90.35M	92.01M	89.56M	83.2M	n/a	n/a	n/a	42.45M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	6.96M	11.7M	25.91M	24.92M	23.62M	n/a	n/a	n/a	n/a
Other Long-Term Assets	-1	952K	15K	15K	1.66M	12.05M	128K	141K	4.63M	2.42M	70K	n/a	2.82M	1.15M	2.63M	-21.22M
Receivables	n/a	2.02M	2.02M	1.92M	6.87M	6.59M	6.49M	5.07M	5.85M	6.52M	6.52M	n/a	2.54M	2.54M	n/a	n/a
Inventory	n/a	n/a	n/a	2.48M	4.12M	-7.21M	-6.49M	4.93M	3.17M	2.22M	-6.52M	4.62M	2.32M	1.48M	n/a	n/a
Other Current Assets	2.86M	1.6M	586K	601K	629K	621K	3M	555K	1.1M	600K	852K	12.61M	1.5M	608K	11K	n/a
Total Current Assets	226M	108.27M	110.25M	112.43M	114.24M	109.37M	134.39M	133.17M	133.08M	133.28M	148.25M	158.63M	104.8M	52.54M	22M	21.22M
Property-Plant & Equipment	21K	111K	199K	286K	372K	662K	471K	585K	697K	807K	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	21K	1.06M	214K	301K	2.03M	12.71M	599K	7.69M	17.03M	29.14M	24.99M	23.62M	2.82M	1.15M	2.63M	-21.22M
Total Assets	226.02M	109.33M	110.47M	112.73M	116.27M	122.08M	134.99M	140.86M	150.1M	162.42M	173.24M	182.25M	107.63M	53.69M	24.63M	n/a
Account Payables	509K	85K	66K	736K	878K	864K	750K	1.49M	1.06M	847K	1.4M	2.58M	1.96M	2M	1.09M	n/a
Deferred Revenue	-509K	-85K	-66K	n/a	n/a	n/a	n/a	-352K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	100K	n/a	334K	401K	485K	464K	n/a	352K	439K	459K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	131K	22K	-196K	-401K	-485K	-464K	n/a	-352K	-439K	-459K	n/a	n/a	n/a	n/a	551K	n/a
Total Current Liabilities	3.74M	2.95M	2.83M	2.9M	3.62M	4.92M	6.1M	6.28M	7.61M	6.9M	6.03M	5.59M	5.71M	4.07M	3.06M	n/a
Long-Term Debt	n/a	n/a	15K	58K	100K	223K	n/a	219K	256K	381K	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	7K	-24K	-45K	-136K	n/a	-219K	-256K	-381K	7K	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	37K	92K	155K	310K	180K	219K	256K	381K	7K	n/a	n/a	n/a	n/a	n/a
Total Liabilities	3.74M	2.95M	2.87M	2.99M	3.77M	5.22M	6.28M	6.5M	7.87M	7.28M	6.04M	5.59M	5.71M	4.07M	3.06M	n/a
Total Debt	100K	225K	349K	459K	585K	687K	480K	571K	695K	840K	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	7K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	1K	1K	1K	n/a
Retained Earnings	-212.56M	-157.68M	-155.98M	-152.34M	-148.37M	-143.15M	-120.86M	-113.1M	-103.42M	-88.82M	-75.62M	-65.07M	-55.46M	-46.74M	-28.14M	n/a
Comprehensive Income	n/a	-0.00	-2K	-11K	-35K	-95K	-358K	-581K	-604K	-521K	-123K	-18K	0.00	n/a	-0.00	-5.56M
Shareholders Equity	222.28M	106.38M	107.6M	109.74M	112.5M	116.86M	128.72M	134.36M	142.24M	155.14M	167.2M	176.66M	101.91M	49.62M	21.57M	20.61M
Total Investments	n/a	n/a	13.69M	50.08M	77.34M	74.94M	79.98M	93.64M	102.05M	117.92M	114.48M	106.82M	n/a	n/a	n/a	42.45M